Theorem Clinical Research has struck a deal with Charles River Laboratories, adding the early-phase-focused CRO's capabilities to its drug development platform.
Now that it has paid about $6.1 million for Warnex's bioanalytics business, France's Biotrial Research is launching an offering all its own.
Swiss CRO Solvias has bought Confarma, a French quality control consultancy.
Swedish CDMO Recipharm is banking on a growing demand for analytical drug development services, planning to reconstruct its Solna, Sweden, facility to house its data-based offerings.
Charles River Laboratories has inked a $27 million deal for 75% of Chinese research model design company Vital River.
Six small CROs are pooling their resources and joining together, looking to capitalize on what they see as a hole in the market for contract research.
Covance is joining forces with GNS Healthcare to use the company's big data know-how to create models for drug-development success.
CoreRx has moved into its new 35,000-square-foot facility in Clearwater, FL, and the new lab will more than triple the CRO's daily capactiy, the company said.
Based on the findings published in Quintiles' annual "New Health Report," payers want to get the ball rolling sooner to get drugs approved faster.
The Canadian CRO gets an extended deadline to repay its debt, while securing a last-minute credit line of $2 million Canadian.